Zealand Pharma: names industry veteran as CEO
(CercleFinance.com) - Zealand Pharma, a Danish biotech company, has appointed Emmanuel Dulac as its new chief executive officer, after the departure of Britt Meelby Jensen last autumn.
Emmanuel Dulac has 25 years' experience in the pharmaceutical industry, having held key posts at Novartis, Abbott, Sanofi and Shire, the firm said.
Since August 2016, he has been the chief commercial officer of US biopharmaceutical company Alnylam.
Britt Meelby Jensen resigned from her position as CEO in November 2018, having been appointed as CEO at Swedish medtech company Atos Medical.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
Emmanuel Dulac has 25 years' experience in the pharmaceutical industry, having held key posts at Novartis, Abbott, Sanofi and Shire, the firm said.
Since August 2016, he has been the chief commercial officer of US biopharmaceutical company Alnylam.
Britt Meelby Jensen resigned from her position as CEO in November 2018, having been appointed as CEO at Swedish medtech company Atos Medical.
Copyright (c) 2019 CercleFinance.com. All rights reserved.